News
Symptoms, and Treatment Liver cancer is one of the most challenging forms of cancer, often developing quietly before showing any clear signs. It begins when abnormal cells form in the liver, a vital ...
The results demonstrated that SCG101 led to sustained clearance of serum hepatitis B surface antigen (HBsAg) and HBV-DNA in heavily pre-treated patients with HBV-related HCC. Notably, 94% of patients ...
The risk of dying from the most common form of primary liver cancer is about 30 percent higher for patients with low household income compared to those with middle or high household income, according ...
More information: Yuchen Liu et al, Disrupting bile acid metabolism by suppressing Fxr causes hepatocellular carcinoma ...
Background: Hepatoblastoma (HBL) and hepatocellular carcinoma (HCC) are respectively the first and the second most common pediatric malignant liver tumors. The purpose of this study was to ...
Hosted on MSN1mon
Statins linked to reduced liver cancer risk in major cohort studythough earlier research often focused narrowly on specific CLD causes or lacked assessment of fibrosis progression. In the study titled "Statin Use and Risk of Hepatocellular Carcinoma and Liver ...
13d
News-Medical.Net on MSNSerum hsa_circ_101555 as a promising biomarker for hepatocellular carcinomaHepatocellular carcinoma (HCC) represents the most prevalent malignancy in Egypt and globally. However, non-invasive diagnostic/prognostic biomarkers for early detection of HCC are still lacking.
The FDA approved nivolumab and ipilimumab for unresectable or metastatic hepatocellular carcinoma, a prevalent and deadly liver cancer in the U.S. CHECKMATE-9DW trial results showed improved ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results